6533b852fe1ef96bd12ab6c3
RESEARCH PRODUCT
A novel flash glucose monitoring system in patients with diabetes mellitus type 1 and 2: which are the pieces of evidence for payer decision-makers?
Natoli GiuseppeCorrao SalvatoreMarika Lo MonacoFrancesco PerticoneBiagio Nativosubject
Blood GlucoseTechnology Assessment BiomedicalBiomedicalEconomicTechnology assessment01 natural sciencesOrganizational03 medical and health sciences0302 clinical medicineHealth careOutcome Assessment Health CareInternal MedicineMedicineHumansIn patientEthic030212 general & internal medicine0101 mathematicsBiomedical technologyMonitoring PhysiologicPoint (typography)business.industryBlood Glucose Self-Monitoring010102 general mathematicsHealth technologyMonitoring systemTechnology assessmentBiomedical technologyDiabetes Mellitus Type 1Risk analysis (engineering)Economic sustainabilityDiabetes Mellitus Type 2Emergency MedicinebusinessDecision makingdescription
A rigorous health technology assessment is necessary to evaluate a new technology. However, healthcare regulatory agencies have less restrictive rules about medical devices, despite some recent warnings about this relevant matter. The evaluation should have at least two key issues, which require attention. The first one is its effectiveness, and the second one is its economic sustainability. In this paper, we deal with a novel glucose-sensing technology as a case study to examine the matter in depth. An evidence-based point of view is used to highlight this important issue.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2018-05-08 | Internal and emergency medicine |